Sofia, July 2025 — DGKV is pleased to announce its role as legal advisor in the successful €2 million investment seed round into Blue Longevity Holdings, a Sofia‑based startup focused on comprehensive preventive and longevity healthcare.
In July 2025, Eleven Ventures, a leading early‑stage VC fund in Southeast Europe, led a €2 million round, supported by Sofia Angels Ventures and a group of private investors. The capital raised will support Blue Longevity Holding’s expansion of its medical team, scaling of AI-driven diagnostics, development of a behavioural health app, and rollout of innovative therapy modules.
Founded in early 2025 by healthcare serial entrepreneurs Ilian Grigorov and Blagoy Palev, Blue Longevity Holdings is set to offer integrative longevity services across health diagnostics, personalized treatment plans, and ongoing digital support. A resident clinic network is slated to open later in 2025 in Athens, Istanbul, and Sofia, covering everything from cryotherapy and hyperbaric oxygen therapy to microbiome and genetic testing.
DGKV advised on the structuring, negotiation, and successful closing of the funding round to Blue Longevity Holdings, drawing on our deep experience in private equity and venture capital transactions.
The DGKV team was led by partner Georgi Tzvetkov supported by associate Irina Mihaylova.